Paper 2: EUROCAT public health indicators for congenital anomalies in Europe

Autor: Khoshnood, B., Greenlees, R., Loane, M., Dolk, H., EUROCAT Project Management Committee, EUROCAT Working Group, Barišić, Ingeborg
Přispěvatelé: Recherche Epidémiologique en Santé Périnatale et Santé des Femmes et des Enfants (UMR_S 953), Université Paris-Sud - Paris 11 (UP11)-Université Pierre et Marie Curie - Paris 6 (UPMC)-Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), EUROCAT Central Registry, Institute for Nursing Research-University of Ulster, the EUROCAT Program Management Committee and a EUROCAT working group, Debs, Nayla, Recherche Epidémiologique en Santé Périnatale et Santé des Femmes et des Enfants ( UMR_S 953 ), Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Université Paris Descartes - Paris 5 ( UPD5 ) -Université Pierre et Marie Curie - Paris 6 ( UPMC ) -Université Paris-Sud - Paris 11 ( UP11 )
Rok vydání: 2011
Předmět:
Embryology
Pediatrics
MESH: Registries
IMPACT
MESH : Stillbirth
Disease
MESH: Abortion
Eugenic

Abortion
DISEASE
MESH: Perinatal Mortality
MESH: Pregnancy
0302 clinical medicine
Pregnancy
TERMINATION
Prenatal Diagnosis
Pediatric surgery
Health Status Indicators
MESH : Female
Neural Tube Defects
Registries
030212 general & internal medicine
Public H
MESH : Malta
MESH : Ukraine
[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologie
MESH: Congenital Abnormalities
General Medicine
Stillbirth
Congenital Anomalies
MESH : Neural Tube Defects
3. Good health
Europe
MESH: Stillbirth
MESH : Perinatal Mortality
MESH: Malta
Gestation
Female
Public Health
MESH : Health Status Indicators
BURDEN
Ukraine
MESH: Public Health
Abortion
Eugenic

medicine.medical_specialty
Down syndrome
MESH : Public Health
MESH : Europe
MESH: Ukraine
MESH: Neural Tube Defects
MESH : Fetal Death
MESH : Abortion
Eugenic

Prenatal diagnosis
Article
Congenital Abnormalities
03 medical and health sciences
MESH: Health Status Indicators
medicine
Indicators
Humans
MESH: Prenatal Diagnosis
Fetal Death
MESH : Prenatal Diagnosis
Perinatal Mortality
MESH: Humans
congenital anomalies
Malta
business.industry
MORTALITY
Public health
RENAC
MESH : Humans
MESH: Down Syndrome
MESH : Congenital Abnormalities
Estados de Saúde e de Doença
medicine.disease
MESH : Down Syndrome
indicators
MESH : Pregnancy
[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie
Pediatrics
Perinatology and Child Health

RISK-FACTORS
MESH: Fetal Death
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
MESH: Europe
Down Syndrome
business
MESH: Female
MESH : Registries
030217 neurology & neurosurgery
Developmental Biology
Zdroj: Birth Defects Research Part A: Clinical and Molecular Teratology
Birth Defects Research Part A: Clinical and Molecular Teratology, Wiley, 2011, 91 Suppl 1, pp.S16-22. ⟨10.1002/bdra.20776⟩
Birth Defects Research Part A: Clinical and Molecular Teratology, 2011, 91 Suppl 1, pp.S16-22. ⟨10.1002/bdra.20776⟩
Birth Defects Research Part A: Clinical and Molecular Teratology, Wiley, 2011, 91 Suppl 1, pp.S16-22. 〈10.1002/bdra.20776〉
ISSN: 1542-0752
1542-0760
DOI: 10.1002/bdra.20776
Popis: OBJECTIVE The purpose of this article is to present the specific public health indicators recently developed by EUROCAT that aim to summarize important aspects of the public health impact of congenital anomalies in a few quantitative measures. METHODS The six indicators are: (1) congenital anomaly perinatal mortality, (2) congenital anomaly prenatal diagnosis prevalence, (3) congenital anomaly termination of pregnancy, (4) Down syndrome livebirth prevalence, (5) congenital anomaly pediatric surgery, and (6) neural tube defects (NTD) total prevalence. Data presented for this report pertained to all cases (livebirths, fetal deaths, or stillbirths after 20 weeks of gestation and terminations of pregnancy for fetal anomaly [TOPFA]) of congenital anomaly from 27 full member registries of EUROCAT that could provide data for at least 3 years during the period 2004 to 2008. Prevalence of anomalies, prenatal diagnosis, TOPFA, pediatric surgery, and perinatal mortality were calculated per 1000 births. RESULTS The overall perinatal mortality was approximately 1.0 per 1000 births for EUROCAT registries with almost half due to fetal and the other half due to first week deaths. There were wide variations in perinatal mortality across the registries with the highest rates observed in Dublin and Malta, registries in countries where TOPFA are illegal, and in Ukraine. The overall perinatal mortality across EUROCAT registries slightly decreased between 2004 and 2008 due to a decrease in first week deaths. The prevalence of TOPFA was fairly stable at about 4 per 1000 births. There were variations in livebirth prevalence of cases typically requiring surgery across the registries; however, for most registries this prevalence was between 3 and 5 per 1000 births. Prevalence of NTD decreased by about 10% from 1.05 in 2004 to 0.94 per 1000 in 2008. CONCLUSION It is hoped that by publishing the data on EUROCAT indicators, the public health importance of congenital anomalies can be clearly summarized to policy makers, the need for accurate data from registries emphasized, the need for primary prevention and treatment services highlighted, and the impact of current services measured. Birth Defects Research (Part A), 2011.© 2011 Wiley-Liss, Inc.
Databáze: OpenAIRE